Drug Approval | April 10, 2024
Shivalik Rasayan’s API facility gets 7 observations from USFDA
These observations are procedural in nature and will be responded within the stipulated time
These observations are procedural in nature and will be responded within the stipulated time
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
The observations are procedural in nature and will be responded to within the stipulated time
The Product is expected to be the first generic approval on the market
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
A game changing solution for the pharmaceutical industry
Highly effective preservation solutions ensuring the safety and protection of personal care products
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The company plans to add 1700 beds by FY27 through the organic route
Subscribe To Our Newsletter & Stay Updated
